🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yi‐Long Wu

Guangdong Academy of Medical Sciences

ORCID: 0000-0002-3611-0258

Also affiliated with Guangdong Provincial People's Hospital, Southern Medical University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer”.

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Journal of Clinical Oncology(2022)10.1200/jco.21.01308
N/A
7.3DataRank · unranked
1324 citations

Corinne Faivre‐Finn, Jhanelle E. Gray, David Vicente, David Planchard, Luis Paz‐Ares +20 more

Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2020.12.015
N/A
6.9DataRank · unranked
471 citations

David Vicente, Takayasu Kurata, David Planchard, Luis Paz‐Ares, Johan Vansteenkiste +18 more

Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition

Nature Medicine(2022)10.1038/s41591-022-01775-6
N/A
0DataRank · unranked
52 citations

Bobby Daly, Mary Gospodarowicz, Monica M. Bertagnolli, Otis W. Brawley, Bruce A. Chabner +29 more

Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

Nature Communications(2023)10.1038/s41467-023-38196-z
N/A
0DataRank · unranked
71 citations

Kouya Shiraishi, Jiyeon Choi, Keitaro Matsuo, Tzu-Yu Chen, Juncheng Dai +95 more

Two decades of advances in clinical oncology — lessons learned and future directions

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00945-4
N/A
0DataRank · unranked
23 citations

Christopher M. Booth, Éduardo Bruera, Markus W. Büchler, Alexander Drilon, Terry J. Fry +14 more

Stratifying Lung Adenocarcinoma Risk with Multi-ancestry Polygenic Risk Scores in East Asian Never-Smokers

medRxiv(2024)10.1101/2024.06.26.24309127
N/A
0DataRank · unranked
0 citations

Xiaoyu Wang, Juncheng Dai, Christiana Karsonaki, Jianxin Shi, Kouya Shiraishi +95 more

Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia

Environment International(2020)10.1016/j.envint.2020.105975
N/A
0DataRank · unranked
27 citations

Jason Y.Y. Wong, Chao A. Hsiung, H. Dean Hosgood, Zhihua Yin, Xiao‐Ou Shu +67 more

Stratifying lung adenocarcinoma risk with multi-ancestry polygenic risk scores in East Asian never-smokers

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf272
N/A
0DataRank · unranked
0 citations

Xiaoyu Wang, Juncheng Dai, Christiana Karsonaki, Jianxin Shi, Kouya Shiraishi +95 more

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100205
N/A
0DataRank · unranked
84 citations

Roy S. Herbst, Gilberto de Castro, Rina Hui, Nir Peled, Dong‐Wan Kim +12 more